Controlled prospective study of treatment for chronic rejection after kidney transplantation by thromboxane synthetase inhibitor.
Teraoka
S
S
Kidney Center, Tokyo Women's Medical College, Japan.
Takahashi
K
K
Toma
H
H
Ota
K
K
D000328:Adult; D002908:Chronic Disease; D003404:Creatinine / Q000097:blood; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy*; D006085:Graft Survival; D006650:Histocompatibility Testing; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008689:Methacrylates / Q000627:therapeutic use*; D011446:Prospective Studies; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors*; D013997:Time Factors
D008689:Methacrylates; D003404:Creatinine; D013930:Thromboxane-A Synthase; C034364:ozagrel